Showing results (541-550 of 2,576) with videos related to
Sort By:
Pageof 258
Molecular Oncology|December 16, 2024
Tonabersat enhances temozolomide-mediated cytotoxicity in glioblastoma by disrupting intercellular connectivity through connexin 43 inhibitionElena N C Schmidt, Bernd O Evert, Barbara E F Pregler, et al.Molecular Oncology|January 10, 2025
Cystatin A promotes the antitumor activity of T helper type 1 cells and dendritic cells in murine models of pancreatic cancerAlessandro Nasti, Shingo Inagaki, Tuyen Thuy Bich Ho, et al.Molecular Oncology|January 3, 2025
Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancerZuojian Hu, Fenglin Shen, Yang Liu, et al.Molecular Oncology|December 7, 2023
PTEN-mediated dephosphorylation of 53BP1 confers cellular resistance to DNA damage in cancer cellsJianfeng He, Caihu Huang, Yanmin Guo, et al.Molecular Oncology|December 30, 2023
Building flexible and robust analysis frameworks for molecular subtyping of cancersChristina Bligaard Pedersen, Benito Campos, Lasse Rene, et al.Molecular Oncology|December 20, 2023
Glucose metabolism in B cell malignancies: a focus on glycolysis branching pathwaysHelga Simon-Molas, Rosita Del Prete, Anna KabanovaMolecular Oncology|December 1, 2023
Preclinical evaluation of the gorilla-derived HAdV-B AdV-lumc007 oncolytic adenovirus 'GoraVir' for the treatment of pancreatic ductal adenocarcinomaSelas T F Bots, Tom J Harryvan, Christianne Groeneveldt, et al.Molecular Oncology|February 13, 2024
Preclinical efficacy of carfilzomib in BRAF-mutant colorectal cancer modelsFederica Maione, Daniele Oddo, Federica Galvagno, et al.Molecular Oncology|January 30, 2024
Plasma-based analysis of ERBB2 mutational status by multiplex digital PCR in a large series of patients with metastatic breast cancerJulien Corné, Véronique Quillien, Florence Godey, et al.Pageof 258